AUDUBON, Pa., March 06, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the 2025 Annual Meeting of ...

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Globus Medical received 510(k) clearance from the Food and Drug Administration (“FDA”) for its ExcelsiusFlex with Total Knee Arthroplasty (“TKA”) application and ACTIFY 3D Total Knee System.

Globus Medical also launched the ExcelsiusFlex robotic navigation platform and the ACTIFY Unicondylar Knee System. The company currently awaits a strong cadence of product launches throughout the ...